Cost-Effectiveness Analysis Of Ivabradine In Heart Failure With Reduced Left Ventricular Ejection Fraction In Spain
- PMID: 27201434
- DOI: 10.1016/j.jval.2014.08.1426
Cost-Effectiveness Analysis Of Ivabradine In Heart Failure With Reduced Left Ventricular Ejection Fraction In Spain
Similar articles
-
Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.Am J Cardiovasc Drugs. 2012 Dec 1;12(6):415-26. doi: 10.2165/11209990-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 23181944 Review.
-
Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.Cardiovasc Res. 2008 Jul 1;79(1):42-51. doi: 10.1093/cvr/cvn057. Epub 2008 Mar 1. Cardiovasc Res. 2008. PMID: 18310678
-
Limited role for ivabradine in the treatment of chronic heart failure.Heart. 2011 Dec;97(23):1961-6. doi: 10.1136/heartjnl-2011-300041. Epub 2011 Sep 13. Heart. 2011. PMID: 21917660
-
A novel mechanism of heart failure with normal ejection fraction.Heart. 2008 Apr;94(4):446-9. doi: 10.1136/hrt.2006.114082. Epub 2007 May 4. Heart. 2008. PMID: 17483129
-
Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.Trends Cardiovasc Med. 2009 Jul;19(5):152-7. doi: 10.1016/j.tcm.2009.09.002. Trends Cardiovasc Med. 2009. PMID: 20005474 Review.
Cited by
-
Ivabradine as adjuvant treatment for chronic heart failure.Cochrane Database Syst Rev. 2020 Nov 4;11(11):CD013004. doi: 10.1002/14651858.CD013004.pub2. Cochrane Database Syst Rev. 2020. PMID: 33147368 Free PMC article.
-
Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF.Eur J Heart Fail. 2020 Nov;22(11):2147-2156. doi: 10.1002/ejhf.1978. Epub 2020 Sep 15. Eur J Heart Fail. 2020. PMID: 32749733 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources